Larvol Delta - AmMax-Bio-Announces-Positive-Phase-2-Results-Demonstrating-ProofofConcept-for-the-Novel-Local-Delivery-of-AMB05X-in-Patients-with-Tenosynovial-Giant-Cell-Tumor-TGCT

AMB-05X - AmMax

https://www.globenewswire.com/news-release/2022/03/02/2395356/0/en/AmMax-Bio-Announces-Positive-Phase-2-Results-Demonstrating-Proof-of-Concept-for-the-Novel-Local-Delivery-of-AMB-05X-in-Patients-with-Tenosynovial-Giant-Cell-Tumor-TGCT.html

Mar 2, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next